Mikhail Eydelman - 09 May 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP, Gen Counsel & Corp Sec
Signature
Mikhail Eydelman, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
09 May 2022
Transactions value $
$0
Form type
4
Filing time
11 May 2022, 17:11:42 UTC
Previous filing
11 Apr 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +225,000 $0.000000 225,000 09 May 2022 Common Stock 225,000 $21.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.